We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$27.7B
1-Year Est. Return
52.44%
This Fund
S&P 500
This Quarter
Est. Return
-13.82%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$9.18B
AUM Growth
-$1.98B
(-18%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
17.16%
Holding
1,256
New
46
Increased
63
Reduced
222
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$108M |
| 2 |
TGI
Triumph Group
TGI
|
+$54M |
| 3 |
Applied Materials
AMAT
|
+$16.4M |
| 4 |
FirstCash
FCFS
|
+$13.5M |
| 5 |
Acuity Brands
AYI
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$60.3M |
| 2 |
ICICI Bank
IBN
|
+$28.4M |
| 3 |
Jabil
JBL
|
+$15.2M |
| 4 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$13.4M |
| 5 |
Banco Bradesco
BBD
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.77% |
| 2 | Industrials | 18.68% |
| 3 | Technology | 16.96% |
| 4 | Healthcare | 10.93% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
126
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22.4M | 0.24% |
568,026
+3,693
| +0.7% | +$172K |
|
127
Albemarle
ALB
$16.2B
| $22M | 0.24% |
285,686
-5,241
| -2% | -$495K |
|
|
ATVI
128
DELISTED
Activision Blizzard
ATVI
| $21.3M | 0.23% |
456,386
+961
| +0.2% | +$57.5K |
|
129
Boston Properties
BXP
$11.1B
| $20.2M | 0.22% |
179,239
-625
| -0.3% | -$75.7K |
|
130
Morgan Stanley
MS
$337B
| $20M | 0.22% |
503,278
-211
| -0% | -$9.21K |
|
131
Becton Dickinson
BDX
$51.6B
| $19.8M | 0.22% |
89,924
-199
| -0.2% | -$46.2K |
|
132
JPMorgan Chase
JPM
$951B
| $19.7M | 0.21% |
201,997
-473
| -0.2% | -$50.4K |
|
133
Automatic Data Processing
ADP
$114B
| $18.5M | 0.2% |
141,041
-353
| -0.2% | -$49.8K |
|
134
United Natural Foods
UNFI
$2.77B
| $18.1M | 0.2% |
1,710,674
-47,119
| -3% | -$991K |
|
135
Labcorp
LH
$27.2B
| $17.9M | 0.2% |
165,095
+1,224
| +0.7% | +$164K |
|
136
Nice
NICE
$6.38B
| $17.9M | 0.19% |
165,237
-17,736
| -10% | -$1.94M |
|
137
Houlihan Lokey
HLI
$9.3B
| $17.5M | 0.19% |
476,170
-15,633
| -3% | -$637K |
|
138
Packaging Corp of America
PKG
$21.4B
| $16.6M | 0.18% |
198,309
+1,398
| +0.7% | +$130K |
|
139
Factset
FDS
$11B
| $16.5M | 0.18% |
82,581
-9
| -0% | -$1.98K |
|
140
Cencora
COR
$61.5B
| $15.8M | 0.17% |
213,035
+1,124
| +0.5% | +$96.9K |
|
|
141
Applied Materials
AMAT
$366B
| $15.7M | 0.17% |
478,424
+477,922
| +95,204% | +$16.4M |
|
142
Dover
DOV
$26.8B
| $15.6M | 0.17% |
219,940
+1,897
| +0.9% | +$155K |
|
143
Petrobras
PBR
$119B
| $15.4M | 0.17% |
1,186,264
-660,193
| -36% | -$9.56M |
|
144
Flex
FLEX
$40.8B
| $15.4M | 0.17% |
2,678,938
+20,313
| +0.8% | +$142K |
|
|
NFX
145
DELISTED
Newfield Exploration
NFX
| $14.5M | 0.16% |
987,977
-27,776
| -3% | -$559K |
|
146
Goldman Sachs
GS
$301B
| $14.1M | 0.15% |
84,621
-161
| -0.2% | -$32.5K |
|
147
Avnet
AVT
$7.27B
| $13.8M | 0.15% |
382,428
-4,318
| -1% | -$177K |
|
|
XEC
148
DELISTED
CIMAREX ENERGY CO
XEC
| $13.1M | 0.14% |
212,393
-2,743
| -1% | -$225K |
|
149
Sonoco
SON
$5.58B
| $13M | 0.14% |
244,162
-5,051
| -2% | -$277K |
|
|
150
Acuity Brands
AYI
$10B
| $12.5M | 0.14% |
108,368
+108,347
| +515,938% | +$13.4M |
|
Similar funds
CAM
UIM
SSA
CM
EARNEST Partners's Q4 2018 Portfolio in Review
As of Q4 2018, EARNEST Partners held 1,256 positions worth $9.18B, down 18% from $11.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
EARNEST Partners's Q4 2018 filing shows 46 new, 63 increased, 222 reduced and 43 closed positions. Its largest new stake was Rio Tinto: 2,204,694 shares worth $107M. The largest sale was Cantel Medical Corporation, an estimated $60.3M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 23% a quarter earlier, followed by Industrials and Technology.
- EARNEST Partners's largest Q4 2018 buy was Rio Tinto: 2,204,694 shares worth $107M.
- EARNEST Partners added most to Applied Materials in Q4 2018, an estimated $16.4M increase.
- EARNEST Partners's biggest Q4 2018 reduction was Cantel Medical Corporation, cutting an estimated $60.3M.
- EARNEST Partners fully exited Energen in Q4 2018, selling an estimated $7.28M.
- EARNEST Partners's ten largest holdings make up 17% of its $9.18B portfolio in Q4 2018.
- EARNEST Partners opened 46 new positions and closed 43 in Q4 2018.
- EARNEST Partners's portfolio value fell 18% quarter-over-quarter to $9.18B.
Based on EARNEST Partners's 13F filing for Q4 2018, filed 14 Feb 2019.